Zevra Therapeutics ZVRA
NASDAQ ZVRA
$12.40 -0.14 (-1.12%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zevra Therapeutics (ZVRA) Net Shares Issued and Repurchased (2015 - 2024)

Analysis

Zevra Therapeutics (ZVRA) Net Shares Issued and Repurchased (2015 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Zevra Therapeutics 734.60 Mn 513.03 Mn 38.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 962,700.00
Dec 31, 2023 5.78 Mn
Dec 31, 2022 1.43 Mn
Dec 31, 2021 919,383.00
Dec 31, 2020 92,869.00
Dec 31, 2019 2.29 Mn
Dec 31, 2018 898,000.00
Dec 31, 2017 919,000.00
Dec 31, 2016 959,375.00
Dec 31, 2015 1.01 Mn
Mar 31, 2015 5,333.00